Georgia McCaughan

10PUBLICATIONS
45CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Regenerative medicine (incl. stem cells)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 08, 2026
Real-world application of the International Myeloma Society (IMS)/International Myeloma Working Group (IMWG) consensus on genomic staging for high-risk multiple myeloma: A report from the Australia and New Zealand Myeloma and Related Diseases Registry.

|Mar 17, 2026
Preferred standard-of-care carfilzomib dosing in multiple myeloma: An international survey of haematologists/oncologists.

Rahul Banerjee, Sharlene Dong, Georgia McCaughan

|Jul 21, 2025
Immunoglobulin prophylaxis should be initiated after bispecific antibody therapy in multiple myeloma, regardless of IgG levels.

Rahul Banerjee, Meera Mohan, Kai Rejeski

|Aug 19, 2024
Variation in immunoglobulin use and impact on survival in myeloma.

Khai Li Chai, Cameron Wellard, Ltp Thao

|Jul 12, 2022
Third-party CMV- and EBV-specific T-cells for first viral reactivation after allogeneic stem cell transplant.

Wei Jiang, Leighton E Clancy, Selmir Avdic

|Jul 07, 2022
Lenalidomide, bortezomib and dexamethasone induction therapy for the treatment of newly diagnosed multiple myeloma: a practical review.

Georgia J McCaughan, Sara Gandolfi, John J Moore

Pageof 2

Frequent Collaborators

2 joint publications

Wei Jiang

2 joint publications

Nada Hamad

2 joint publications

P Joy Ho

2 joint publications

Emily Blyth